{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:32:44Z","timestamp":1791408764256,"version":"4.3.3"},"reference-count":158,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T00:00:00Z","timestamp":1638230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Phospholipase A2 (PLA2) enzymes were first recognized as an enzyme activity class in 1961. The secreted (sPLA2) enzymes were the first of the five major classes of human PLA2s to be identified and now number nine catalytically-active structurally homologous proteins. The best-studied of these, group IIA sPLA2, has a clear role in the physiological response to infection and minor injury and acts as an amplifier of pathological inflammation. The enzyme has been a target for anti-inflammatory drug development in multiple disorders where chronic inflammation is a driver of pathology since its cloning in 1989. Despite intensive effort, no clinically approved medicines targeting the enzyme activity have yet been developed. This review catalogues the major discoveries in the human group IIA sPLA2 field, focusing on features of enzyme function that may explain this lack of success and discusses future research that may assist in realizing the potential benefit of targeting this enzyme. Functionally-selective inhibitors together with isoform-selective inhibitors are necessary to limit the apparent toxicity of previous drugs. There is also a need to define the relevance of the catalytic function of hGIIA to human inflammatory pathology relative to its recently-discovered catalysis-independent function.<\/jats:p>","DOI":"10.3390\/molecules26237267","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T22:01:11Z","timestamp":1638309671000},"page":"7267","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Human Group IIA Phospholipase A2\u2014Three Decades on from Its Discovery"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6012-4107","authenticated-orcid":false,"given":"Kieran F.","family":"Scott","sequence":"first","affiliation":[{"name":"School of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia"},{"name":"Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Mann","sequence":"additional","affiliation":[{"name":"School of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia"},{"name":"Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadma","family":"Fatima","sequence":"additional","affiliation":[{"name":"School of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia"},{"name":"Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia"},{"name":"School of Biotechnology and Biological Sciences, University of New South Wales (UNSW Sydney), Sydney, NSW 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mila","family":"Sajinovic","sequence":"additional","affiliation":[{"name":"Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anshuli","family":"Razdan","sequence":"additional","affiliation":[{"name":"Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3810-9514","authenticated-orcid":false,"given":"Ryung Rae","family":"Kim","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Cooper","sequence":"additional","affiliation":[{"name":"School of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia"},{"name":"Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia"},{"name":"Liverpool Cancer Therapy Centre, Liverpool Hospital, Liverpool, NSW 2170, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aflah","family":"Roohullah","sequence":"additional","affiliation":[{"name":"School of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia"},{"name":"Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia"},{"name":"Liverpool Cancer Therapy Centre, Liverpool Hospital, Liverpool, NSW 2170, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine J.","family":"Bryant","sequence":"additional","affiliation":[{"name":"School of Photovoltaic and Renewable Energy Engineering, UNSW Sydney, Sydney, NSW 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasuni K.","family":"Gamage","sequence":"additional","affiliation":[{"name":"School of Science, Western Sydney University, Campbelltown, NSW 2560, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Harman","sequence":"additional","affiliation":[{"name":"School of Science, Western Sydney University, Campbelltown, NSW 2560, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Vafaee","sequence":"additional","affiliation":[{"name":"School of Biotechnology and Biological Sciences, University of New South Wales (UNSW Sydney), Sydney, NSW 2052, Australia"},{"name":"UNSW Data Science Hub, UNSW Sydney, Sydney, NSW 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garry G.","family":"Graham","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, St Vincent\u2019s Hospital Sydney, Darlinghurst, NSW 2010, Australia"},{"name":"School of Medical Sciences, UNSW Sydney, Sydney, NSW 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8033-5518","authenticated-orcid":false,"given":"W. Bret","family":"Church","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela J.","family":"Russell","sequence":"additional","affiliation":[{"name":"Australian Prostate Cancer Research Centre\u2014QUT, Brisbane, QLD 4102, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihan","family":"Dong","sequence":"additional","affiliation":[{"name":"Chinese Medicine Anti-Cancer Evaluation Program, Greg Brown Laboratory, Central Clinical School and Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"de Souza","sequence":"additional","affiliation":[{"name":"School of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia"},{"name":"Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia"},{"name":"School of Medicine, UNSW Sydney, Sydney, NSW 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,30]]},"reference":[{"key":"ref_1","unstructured":"(2021, October 19). KEGG Database. Available online: https:\/\/www.genome.jp\/dbget-bin\/www_bget?ec:3.1.1.4."},{"key":"ref_2","unstructured":"(2021, October 17). OVID Search of Embase Database. Available online: https:\/\/www.embase.com\/landing?status=grey."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"13057","DOI":"10.1016\/S0021-9258(17)36794-7","article-title":"Diversity of group types, regulation, and function of phospholipase A2","volume":"269","author":"Dennis","year":"1994","journal-title":"J. Biol. Chem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.bbalip.2006.07.011","article-title":"The phospholipase A2 superfamily and its group numbering system","volume":"1761","author":"Schaloske","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"38C","DOI":"10.1042\/bj1050038C","article-title":"The positional specificity of lysosomal phospholipase A activities","volume":"105","author":"Winkler","year":"1967","journal-title":"Biochem. J."},{"key":"ref_6","first-page":"192","article-title":"On the biochemistry of bee venom peptides, melittin and apamin","volume":"343","author":"Habermann","year":"1965","journal-title":"Biochem. Z."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0005-2744(68)90248-9","article-title":"Purification and properties of phospholipase A from porcine pancreas","volume":"159","author":"Postema","year":"1968","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1021\/bi00829a057","article-title":"Studies on phospholipase A. I. Isolation and characterization of two enzymes from Crotalus adamanteus venom","volume":"8","author":"Wells","year":"1969","journal-title":"Biochemistry"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1021\/bi00832a035","article-title":"Phospholipase A from Crotalus atrox venom. I. Purification and some properties","volume":"8","author":"Wu","year":"1969","journal-title":"Biochemistry"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0022-2836(78)90146-8","article-title":"Three-dimensional structure and disulfide bond connections in bovine pancreatic phospholipase A2","volume":"124","author":"Dijkstra","year":"1978","journal-title":"J. Mol. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0022-2836(81)90081-4","article-title":"Structure of bovine pancreatic phospholipase A2 at 1.7A resolution","volume":"147","author":"Dijkstra","year":"1981","journal-title":"J. Mol. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1016\/S0021-9258(17)40140-2","article-title":"Amino acid sequence of phospholipase A2-alpha from the venom of Crotalus adamanteus. A new classification of phospholipases A2 based upon structural determinants","volume":"252","author":"Heinrikson","year":"1977","journal-title":"J. Biol. Chem."},{"key":"ref_13","first-page":"1419","article-title":"Trypsin activation of phospholipase A2 from human and rat pancreatic juice","volume":"50","author":"Belleville","year":"1968","journal-title":"Bull. Soc. Chim. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"16P","DOI":"10.1042\/bj1150016Pb","article-title":"Phospholipases in cerebrospinal fluid and cell fractions of human brain","volume":"115","author":"Illingworth","year":"1969","journal-title":"Biochem. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1111\/j.1471-4159.1970.tb03724.x","article-title":"The differentiation of phospholipase A1 and A2 in rat and human nervous tissues","volume":"17","author":"Cooper","year":"1970","journal-title":"J. Neurochem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/978-1-4615-9071-2_15","article-title":"Mechanism of phospholipase A2 action toward mixed micelles of detergent and phospholipids","volume":"101","author":"Dennis","year":"1978","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1016\/S0021-9258(18)91075-6","article-title":"Kinetic analysis of the dual phospholipid model for phospholipase A2 action","volume":"259","author":"Hendrickson","year":"1984","journal-title":"J. Biol. Chem."},{"key":"ref_18","first-page":"873","article-title":"Elevated plasma phospholipase A2 levels: Correlation with the hemodynamic and pulmonary changes in gram-negative septic shock","volume":"104","author":"Vadas","year":"1984","journal-title":"J. Lab. Clin. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0024-3205(85)90640-X","article-title":"Characterization of extracellular phospholipase A2 in rheumatoid synovial fluid","volume":"36","author":"Vadas","year":"1985","journal-title":"Life Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/oxfordjournals.jbchem.a121836","article-title":"Purification of a soluble phospholipase A2 from synovial fluid in rheumatoid arthritis","volume":"100","author":"Stefanski","year":"1986","journal-title":"J. Biochem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/oxfordjournals.jbchem.a122467","article-title":"Amino acid composition and NH2-terminal amino acid sequence of human phospholipase A2 purified from rheumatoid synovial fluid","volume":"104","author":"Hara","year":"1988","journal-title":"J. Biochem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1016\/S0021-9258(18)83616-X","article-title":"Structure and properties of a human non-pancreatic phospholipase A2","volume":"264","author":"Kramer","year":"1989","journal-title":"J. Biol. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1016\/S0021-9258(18)83549-9","article-title":"Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid","volume":"264","author":"Seilhamer","year":"1989","journal-title":"J. Biol. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/1046-5928(91)90061-M","article-title":"A strategy for obtaining active mammalian enzyme from a fusion protein expressed in bacteria using phospholipase A2 as a model","volume":"2","author":"Tseng","year":"1991","journal-title":"Protein Expr. Purif."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-1-4684-5805-3_2","article-title":"Localization and evolution of two human phospholipase A2 genes and two related genetic elements","volume":"275","author":"Johnson","year":"1990","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/0006-291X(90)90666-B","article-title":"Monoclonal antibodies against human synovial phospholipase A2","volume":"167","author":"Takayama","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF00917352","article-title":"Circulating phospholipase A2 activity associated with sepsis and septic shock is indistinguishable from that associated with rheumatoid arthritis","volume":"15","author":"Green","year":"1991","journal-title":"Inflammation"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/rheumatology\/31.3.175","article-title":"Measurement of human phospholipase A2 in arthritis plasma using a newly developed sandwich ELISA","volume":"31","author":"Smith","year":"1992","journal-title":"Br. J. Rheumatol."},{"key":"ref_29","first-page":"9","article-title":"Elevated maternal plasma immunoreactive phospholipase A2 in human preterm and term labour","volume":"5","author":"Rice","year":"1992","journal-title":"Eicosanoids"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1128\/iai.60.9.3928-3931.1992","article-title":"Induction of circulating group II phospholipase A2 expression in adults with malaria","volume":"60","author":"Vadas","year":"1992","journal-title":"Infect. Immun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0021-9150(96)05946-1","article-title":"Expression of secretory group II phospholipase A2 by CD1a positive cells-in human atherosclerotic plaques","volume":"127","author":"Bobryshev","year":"1996","journal-title":"Atherosclerosis"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/ard.57.9.550","article-title":"Increased expression of human type IIa secretory phospholipase A2 antigen in arthritic synovium","volume":"57","author":"Jamal","year":"1998","journal-title":"Ann. Rheum. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/352079a0","article-title":"Structure of recombinant human rheumatoid arthritic synovial fluid phospholipase A2 at 2.2 A resolution","volume":"352","author":"Wery","year":"1991","journal-title":"Nature"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1001\/jama.2013.282836","article-title":"Varespladib and cardiovascular events in patients with an acute coronary syndrome: The VISTA-16 randomized clinical trial","volume":"311","author":"Nicholls","year":"2014","journal-title":"J. Am. Med. Assoc."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1194\/jlr.R058123","article-title":"A new era of secreted phospholipase A2","volume":"56","author":"Murakami","year":"2015","journal-title":"J. Lipid Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/jlb.66.4.535","article-title":"Functional coupling and differential regulation of the phospholipase A2-cyclooxygenase pathways in inflammation","volume":"66","author":"Scott","year":"1999","journal-title":"J. Leukoc. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"20124","DOI":"10.1074\/jbc.M611883200","article-title":"A novel role of group VIB calcium-independent phospholipase A2 (iPLA2gamma) in the inducible expression of group IIA secretory PLA2 in rat fibroblastic cells","volume":"282","author":"Kuwata","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1021\/cr200085w","article-title":"Phospholipase A2 enzymes: Physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention","volume":"111","author":"Dennis","year":"2011","journal-title":"Chem. Rev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.biochem.76.062405.154007","article-title":"Biochemistry and physiology of mammalian secreted phospholipases A2","volume":"77","author":"Lambeau","year":"2008","journal-title":"Annu. Rev. Biochem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/emmm.201000072","article-title":"A novel anti-inflammatory role for secretory phospholipase A2 in immune complex-mediated arthritis","volume":"2","author":"Boilard","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1084\/jem.20121887","article-title":"Lymphoid tissue phospholipase A2 group IID resolves contact hyperesensitvty by driving anti-inflammatory lipid mediators","volume":"210","author":"Miki","year":"2013","journal-title":"J. Exp. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1021\/jm060136t","article-title":"The first potent inhibitor of mammalian group X sectreted phospholipase A2: Elucidation of sites of enhanced binding","volume":"49","author":"Smart","year":"2006","journal-title":"J. Med. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbalip.2007.12.001","article-title":"Antibacterial actions of secreted phospholipases A2. Review","volume":"1781","author":"Nevalainen","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.bbalip.2018.08.017","article-title":"Roles of secreted phospholipase A2 group IIA in inflammation and host defense","volume":"1864","author":"Dore","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1042\/bj3210737","article-title":"High specificity of human secretory class II phospholipase A2 for phosphatidic acid","volume":"321","author":"Snitko","year":"1997","journal-title":"Biochem. J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"14325","DOI":"10.1021\/bi971200z","article-title":"Mapping the interfacial binding surface of human secretory group IIa phospholipase A2","volume":"36","author":"Snitko","year":"1997","journal-title":"Biochemistry"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"48535","DOI":"10.1074\/jbc.M205855200","article-title":"Interfacial kinetic and binding properties of the complete set of human and mouse groups I, II, V, X, and XII secreted phospholipases A2","volume":"277","author":"Singer","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"48523","DOI":"10.1074\/jbc.M203137200","article-title":"On the binding preference of human groups IIA and X phospholipases A2 for membranes with anionic phospholipids","volume":"277","author":"Bezzine","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1074\/jbc.275.5.3179","article-title":"Exogenously added human group X secreted phospholipase A2 but not the group IB, IIA, and V enzymes efficiently release arachidonic acid from adherent mammalian cells","volume":"275","author":"Bezzine","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0005-2760(97)00082-9","article-title":"The perturbed membrane of cells undergoing apoptosis is susceptible to type II secretory phospholipase A2 to liberate arachidonic acid","volume":"1349","author":"Atsumi","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1172\/JCI107915","article-title":"Partial characterization and purification of a rabbit granulocyte factor that increases permeability of Escherichia coli","volume":"55","author":"Weiss","year":"1975","journal-title":"J. Clin. Investig."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"11000","DOI":"10.1016\/S0021-9258(19)86622-X","article-title":"Separation and purification of a potent bactericidal\/permeability-increasing protein and a closely associated phospholipase A2 from rabbit polymorphonuclear leukocytes. Observations on their relationship","volume":"254","author":"Elsbach","year":"1979","journal-title":"J. Biol. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"11010","DOI":"10.1016\/S0021-9258(19)86623-1","article-title":"Determinants of the action of phospholipases A on the envelope phospholipids of Escherichia coli","volume":"254","author":"Weiss","year":"1979","journal-title":"J. Biol. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1172\/JCI3121","article-title":"Mobilization of potent plasma bactericidal activity during systemic bacterial challenge. Role of group IIA phospholipase A2","volume":"102","author":"Weinrauch","year":"1998","journal-title":"J. Clin. Investig."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.4049\/jimmunol.162.12.7402","article-title":"Protection by group II phospholipase A2 against Staphylococcus aureus","volume":"162","author":"Laine","year":"1999","journal-title":"J. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1146\/annurev-micro-092412-155620","article-title":"Wall teichoic acids of gram-positive bacteria","volume":"67","author":"Brown","year":"2013","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1172\/JCI5468","article-title":"Cell-wall determinants of the bactericidal action of group IIA phospholipase A2 against Gram-positive bacteria","volume":"103","author":"Weinrauch","year":"1999","journal-title":"J. Clin. Investig."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1128\/JB.01155-13","article-title":"Lipoteichoic acids, phosphate-containing polymers in the envelope of gram-positive bacteria","volume":"196","author":"Schneewind","year":"2014","journal-title":"J. Bacteriol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"47636","DOI":"10.1074\/jbc.M205104200","article-title":"Role of charge properties of bacterial envelope in bactericidal action of human group IIA phospholipase A2 against Staphylococcus aureus","volume":"277","author":"Koprivnjak","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"5849","DOI":"10.1074\/jbc.M109699200","article-title":"Bactericidal properties of human and murine groups I, II, V, X, and XII secreted phospholipases A2","volume":"277","author":"Koduri","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1388-1981(00)00111-6","article-title":"The antibacterial properties of secreted phospholipases A2","volume":"1488","author":"Buckland","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"10301","DOI":"10.1021\/bi970176m","article-title":"Mechanisms of action of the bactericidal\/permeability-increasing protein BPI on endotoxin and phospholipid monolayers and aggregates","volume":"36","author":"Wiese","year":"1997","journal-title":"Biochemistry"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1007\/s12010-013-0113-6","article-title":"Secretory phospholipase A2 in dromedary tears: A host defense against staphylococci and other gram-positive bacteria","volume":"169","author":"Abid","year":"2013","journal-title":"Appl. Biochem. Biotechnol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Kim, R.R., Chen, Z., Mann, T.J., Bastard, K., Scott, K.F., and Church, W.B. (2020). Structural and Functional Aspects of Targeting the Secreted Human Group IIA Phospholipase A2. Molecules, 25.","DOI":"10.3390\/molecules25194459"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e00556-19","DOI":"10.1128\/IAI.00556-19","article-title":"Antimalarial Activity of Human Group IIA Secreted Phospholipase A2 in Relation to Enzymatic Hydrolysis of Oxidized Lipoproteins","volume":"87","author":"Dacheux","year":"2019","journal-title":"Infect. Immun."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/BF00916585","article-title":"Distribution of pancreatic (group I) and synovial-type (group II) phospholipases A2 in human tissues","volume":"17","author":"Nevalainen","year":"1993","journal-title":"Inflammation"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.4049\/jimmunol.164.9.4908","article-title":"Secretory phospholipases A2 induce beta-glucuronidase release and IL-6 production from human lung macrophages","volume":"164","author":"Triggiani","year":"2000","journal-title":"J. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4049\/jimmunol.174.1.464","article-title":"Activation of cytokine production by secreted phospholipase A2 in human lung macrophages expressing the M-type receptor","volume":"174","author":"Granata","year":"2005","journal-title":"J. Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.4049\/jimmunol.0902501","article-title":"Production of vascular endothelial growth factors from human lung macrophages induced by group IIA and group X secreted phospholipases A2","volume":"184","author":"Granata","year":"2010","journal-title":"J. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nri3859","article-title":"Eicosanoid storm in infection and inflammation","volume":"15","author":"Dennis","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/carcin\/bgq188","article-title":"Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer","volume":"31","author":"Dong","year":"2010","journal-title":"Carcinogenesis"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.4049\/jimmunol.161.7.3421","article-title":"Selective inhibitors of cytosolic or secretory phospholipase A2 block TNF-induced activation of transcription factor nuclear factor-kappa B and expression of ICAM-1","volume":"161","author":"Thommesen","year":"1998","journal-title":"J. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3892\/ijo.2014.2486","article-title":"Secretory phospholipase A2-IIa upregulates HER\/HER2-elicited signaling in lung cancer cells","volume":"45","author":"Dong","year":"2014","journal-title":"Int. J. Oncol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"38658","DOI":"10.1074\/jbc.M106599200","article-title":"Positive and negative regulation of NF-kappaB by COX-2: Roles of different prostaglandins","volume":"276","author":"Poligone","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejca.2016.10.011","article-title":"Molecular lipid species in urinary exosomes as potential prostate cancer biomarkers","volume":"70","author":"Skotland","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"E3564","DOI":"10.1073\/pnas.1507905112","article-title":"Platelet microparticles are internalized in neutrophils via the concerted activity of 12-lipoxygenase and secreted phospholipase A2-IIA","volume":"112","author":"Duchez","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1749-6632.2000.tb06550.x","article-title":"Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer","volume":"905","author":"Fang","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"R234","DOI":"10.1186\/ar787","article-title":"Extracellular mitochondrial DNA and oxidatively damaged DNA in synovial fluid of patients with rheumatoid arthritis","volume":"5","author":"Hajizadeh","year":"2003","journal-title":"Arthritis Res. Ther."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1182\/blood-2014-05-573543","article-title":"Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation","volume":"124","author":"Boudreau","year":"2014","journal-title":"Blood"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1385\/MN:31:1-3:027","article-title":"Phospholipase A2 in astrocytes: Responses to oxidative stress, inflammation, and G protein-coupled receptor agonists","volume":"31","author":"Sun","year":"2005","journal-title":"Mol. Neurobiol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/157015906775203011","article-title":"Cerebral arachidonate cascade in dementia: Alzheimer\u2019s disease and vascular dementia","volume":"4","author":"Yagami","year":"2006","journal-title":"Curr. Neuropharmacol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2174\/187152708784936671","article-title":"Role of secretory phospholipase a2 in CNS inflammation: Implications in traumatic spinal cord injury","volume":"7","author":"Titsworth","year":"2008","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12017-009-8092-z","article-title":"Phospholipases A2 and inflammatory responses in the central nervous system","volume":"12","author":"Sun","year":"2010","journal-title":"Neuromol. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jchemneu.2010.02.002","article-title":"Expression profile of multiple secretory phospholipase A2 isoforms in the rat CNS: Enriched expression of sPLA2-IIA in brainstem and spinal cord","volume":"39","author":"Ma","year":"2010","journal-title":"J. Chem. Neuroanat."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1074\/jbc.273.1.606","article-title":"Secretory phospholipase A2 activates the cascade of mitogen-activated protein kinases and cytosolic phospholipase A2 in the human astrocytoma cell line 1321N1","volume":"273","author":"Hernandez","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1006\/bbrc.1999.0832","article-title":"Secretory phospholipase A2 induces phospholipase Cgamma-1 activation and Ca2+ mobilization in the human astrocytoma cell line 1321N1 by a mechanism independent of its catalytic activity","volume":"260","author":"Hernandez","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.mcn.2012.02.006","article-title":"Secreted phospholipase A2 group IIA is a neurotoxin released by stimulated human glial cells","volume":"49","author":"Villanueva","year":"2012","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.neuroscience.2021.04.026","article-title":"Bioactive Lipid Mediators in the Initiation and Resolution of Inflammation after Spinal Cord Injury","volume":"466","author":"David","year":"2021","journal-title":"Neuroscience"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"9895","DOI":"10.1007\/s11033-020-06033-x","article-title":"Exploring the molecular approach of COX and LOX in Alzheimer\u2019s and Parkinson\u2019s disorder","volume":"47","author":"Kumar","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"730","DOI":"10.2174\/1381612826666200107141328","article-title":"Role of Prostaglandins in Multiple Sclerosis","volume":"26","author":"Gulla","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1073\/pnas.77.6.3710","article-title":"Slow reacting substances of anaphylaxis: Identification of leukotrienes C-1 and D from human and rat sources","volume":"77","author":"Lewis","year":"1980","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1164\/ajrccm.155.2.9032172","article-title":"Phospholipase A2 and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics","volume":"155","author":"Bowton","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1365-2222.2010.03676.x","article-title":"Relationship between levels of secreted phospholipase A2 groups IIA and X in the airways and asthma severity","volume":"41","author":"Hallstrand","year":"2011","journal-title":"Clin. Exp. Allergy"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.imbio.2009.06.006","article-title":"Secreted phospholipases A2: A proinflammatory connection between macrophages and mast cells in the human lung","volume":"214","author":"Granata","year":"2009","journal-title":"Immunobiology"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1084\/jem.20070029","article-title":"Importance of group X-secreted phospholipase A2 in allergen-induced airway inflammation and remodeling in a mouse asthma model","volume":"204","author":"Henderson","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"793505","DOI":"10.1155\/2013\/793505","article-title":"The involvement of phospholipases A2 in asthma and chronic obstructive pulmonary disease","volume":"2013","author":"Pniewska","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e149236","DOI":"10.1172\/JCI149236","article-title":"Group IIA secreted phospholipase A2 is associated with the pathobiology leading to COVID-19 mortality","volume":"131","author":"Snider","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12964-020-00687-7","article-title":"Phosphatidylserine inside out: A possible underlying mechanism in the inflammation and coagulation abnormalities of COVID-19","volume":"18","author":"Arganaraz","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Kuypers, F.A., Rostad, C.A., Anderson, E.J., Chahroudi, A., Jaggi, P., Wrammert, J., Mantus, G., Basu, R., Harris, F., and Hanberry, B. (2021). Secretory phospholipase A2 in SARS-CoV-2 infection and multisystem inflammatory syndrome in children (MIS-C). Exp. Biol. Med., 1\u201310.","DOI":"10.1177\/15353702211028560"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nrcardio.2013.220","article-title":"Acute coronary syndromes: Targeting inflammation-what has the VISTA-16 trial taught us?","volume":"11","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"10077","DOI":"10.1074\/jbc.275.14.10077","article-title":"Overexpression of secretory phospholipase A2 causes rapid catabolism and altered tissue uptake of high density lipoprotein cholesteryl ester and apolipoprotein A-I","volume":"275","author":"Tietge","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1093\/eurheartj\/ehs148","article-title":"Phospholipase A2 enzymes and the risk of atherosclerosis","volume":"33","author":"Rosenson","year":"2012","journal-title":"Eur. Heart J."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0008-6363(03)00324-9","article-title":"Type II secretory phospholipase A2 in cardiovascular disease: A mediator in atherosclerosis and ischemic damage to cardiomyocytes?","volume":"60","author":"Niessen","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1161\/01.CIR.100.12.1280","article-title":"Circulating levels of secretory type II phospholipase A2 predict coronary events in patients with coronary artery disease","volume":"100","author":"Kugiyama","year":"1999","journal-title":"Circulation"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"11369","DOI":"10.1038\/s41598-021-90894-0","article-title":"Comparison of sPLA2IIA performance with high-sensitive CRP neutrophil percentage PCT and lactate to identify bacterial infection","volume":"11","author":"Tan","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e12460","DOI":"10.1002\/emp2.12460","article-title":"Group IIA secretory phospholipase 2 independently predicts mortality and positive blood culture in emergency department sepsis patients","volume":"2","author":"Nandi","year":"2021","journal-title":"J. Am. Coll. Emerg. Physicians Open"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1097\/CCM.0000000000003206","article-title":"Derivation and Validation of a Biomarker-Based Clinical Algorithm to Rule Out Sepsis From Noninfectious Systemic Inflammatory Response Syndrome at Emergency Department Admission: A Multicenter Prospective Study","volume":"46","author":"Mearelli","year":"2018","journal-title":"Crit. Care Med."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1097\/01.CCM.0000171540.54520.69","article-title":"LY315920NA\/S-5920, a selective inhibitor of group IIA secretory phospholipase A2, fails to improve clinical outcome for patients with severe sepsis","volume":"33","author":"Zeiher","year":"2005","journal-title":"Crit. Care Med."},{"key":"ref_109","first-page":"1162","article-title":"Secretory phospholipase A2 as an index of disease activity in rheumatoid arthritis. Prospective double blind study of 212 patients","volume":"23","author":"Lin","year":"1996","journal-title":"J. Rheumatol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1074\/jbc.M110.123927","article-title":"A bifunctional role for group IIA secreted phospholipase A2 in human rheumatoid fibroblast-like synoviocyte arachidonic acid metabolism","volume":"286","author":"Bryant","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"15269","DOI":"10.1074\/jbc.M112.397893","article-title":"Selective inhibition of human group IIA-secreted phospholipase A2 (hGIIA) signaling reveals arachidonic acid metabolism is associated with colocalization of hGIIA to vimentin in rheumatoid synoviocytes","volume":"288","author":"Lee","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"25679","DOI":"10.1073\/pnas.2005111117","article-title":"Synergy between 15-lipoxygenase and secreted PLA2 promotes inflammation by formation of TLR4 agonists from extracellular vesicles","volume":"117","author":"Ha","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_113","first-page":"417","article-title":"A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis","volume":"32","author":"Bradley","year":"2005","journal-title":"J. Rheumatol."},{"key":"ref_114","first-page":"241","article-title":"Elevation of serum group II phospholipase A2 in patients with cancers of digestive organs","volume":"74","author":"Ogawa","year":"1991","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/bjc.1994.229","article-title":"Overexpression of group II phospholipase A2 in human breast cancer tissues is closely associated with their malignant potency","volume":"69","author":"Yamashita","year":"1994","journal-title":"Br. J. Cancer"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.2741\/2998","article-title":"The roles of sPLA2-IIA (Pla2g2a) in cancer of the small and large intestine","volume":"13","author":"Fijneman","year":"2008","journal-title":"Front. Biosci."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.biochi.2010.03.019","article-title":"Emerging roles for phospholipase A2 enzymes in cancer","volume":"92","author":"Scott","year":"2010","journal-title":"Biochimie"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.biochi.2014.09.023","article-title":"Secreted phospholipases A2 in cancer: Diverse mechanisms of action","volume":"107","author":"Brglez","year":"2014","journal-title":"Biochimie"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"606","DOI":"10.2174\/1573406413666170209121317","article-title":"A Concise Update on the Relevance of Secretory Phospholipase A2 Group IIA and its Inhibitors with Cancer","volume":"13","author":"Chen","year":"2017","journal-title":"Med. Chem."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.canlet.2020.10.021","article-title":"Phospholipase A2 superfamily in cancer","volume":"497","author":"Peng","year":"2021","journal-title":"Cancer Lett."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"6934","DOI":"10.1158\/0008-5472.CAN-03-3018","article-title":"Oncogenic action of secreted phospholipase A2 in prostate cancer","volume":"64","author":"Sved","year":"2004","journal-title":"Cancer Res."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc1143","article-title":"The emerging role of lysophosphatidic acid in cancer","volume":"3","author":"Mills","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc2809","article-title":"Eicosanoids and cancer","volume":"10","author":"Wang","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"ref_124","unstructured":"Cormier, R.T. (2021, March 22). PLA2G2A (Phospholipase A2, Group IIA (Platelets, Synovial Fluid). Atlas of Genetics and Cytogen-etics in Oncology and Haematology. Available online: http:\/\/atlasgeneticsoncology.org\/Genes\/PLA2G2AID41730ch1p36.html."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.bcp.2007.04.021","article-title":"Phospholipase A2 as targets for anti-cancer drugs","volume":"74","author":"Cummings","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.canlet.2005.08.012","article-title":"Oncogenic action of phospholipase A2 in prostate cancer","volume":"240","author":"Dong","year":"2006","journal-title":"Cancer Lett."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"9325","DOI":"10.1073\/pnas.88.20.9325","article-title":"Critical role of a hydrogen bond in the interaction of phospholipase A2 with transition-state and substrate analogues","volume":"88","author":"Yu","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1021\/cr990139w","article-title":"Interfacial enzymology: The secreted phospholipase A2-paradigm","volume":"101","author":"Berg","year":"2001","journal-title":"Chem. Rev."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"13203","DOI":"10.1021\/bi981223t","article-title":"Tryptophan-containing mutant of human (group IIa) secreted phospholipase A2 has a dramatically increased ability to hydrolyze phosphatidylcholine vesicles and cell membranes","volume":"37","author":"Baker","year":"1998","journal-title":"Biochemistry"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-biochem-060409-092612","article-title":"Applications of mass spectrometry to lipids and membranes","volume":"80","author":"Harkewicz","year":"2011","journal-title":"Annu. Rev. Biochem."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cell.2015.12.035","article-title":"Biology and Applications of CRISPR Systems: Harnessing Nature\u2019s Toolbox for Genome Engineering","volume":"164","author":"Wright","year":"2016","journal-title":"Cell"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/neuonc\/noq078","article-title":"Secreted PLA2 induces proliferation in astrocytoma through the EGF receptor: Another inflammation-cancer link","volume":"12","author":"Hernandez","year":"2010","journal-title":"Neuro Oncol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.4049\/jimmunol.165.5.2790","article-title":"Type IIA secretory phospholipase A2 up-regulates cyclooxygenase-2 and amplifies cytokine-mediated prostaglandin production in human rheumatoid synoviocytes","volume":"165","author":"Bidgood","year":"2000","journal-title":"J. Immunol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.3892\/ijo.2017.3964","article-title":"Overexpression of secretory phospholipase A2-IIa supports cancer stem cell phenotype via HER\/ERBB-elicited signaling in lung and prostate cancer cells","volume":"50","author":"Lu","year":"2017","journal-title":"Int. J. Oncol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"29927","DOI":"10.1074\/jbc.274.42.29927","article-title":"Functional association of type IIA secretory phospholipase A2 with the glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan in the cyclooxygenase-2-mediated delayed prostanoid-biosynthetic pathway","volume":"274","author":"Murakami","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"25024","DOI":"10.1074\/jbc.M313019200","article-title":"Arachidonic acid release from mammalian cells transfected with human groups IIA and X secreted phospholipase A2 occurs predominantly during the secretory process and with the involvement of cytosolic phospholipase A2-alpha","volume":"279","author":"Mounier","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1074\/jbc.M114.579946","article-title":"Proinflammatory secreted phospholipase A2 type IIA (sPLA-IIA) induces integrin activation through direct binding to a newly identified binding site (site 2) in integrins alphavbeta3, alpha4beta1, and alpha5beta1","volume":"290","author":"Fujita","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-cellbio-100617-062534","article-title":"Cytoplasmic Intermediate Filaments in Cell Biology","volume":"34","year":"2018","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_139","first-page":"1068","article-title":"Interaction of low molecular weight group IIA phospholipase A2 with apoptotic human T cells: Role of heparan sulfate proteoglycans","volume":"17","author":"Boilard","year":"2003","journal-title":"Fed. Am. Soc. Exp. Biol. J."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1074\/jbc.275.2.1161","article-title":"Identification of a cellular protein that functionally interacts with the C2 domain of cytosolic phospholipase A2alpha","volume":"275","author":"Nakatani","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jmb.2006.09.056","article-title":"Vimentin binding to phosphorylated Erk sterically hinders enzymatic dephosphorylation of the kinase","volume":"364","author":"Perlson","year":"2006","journal-title":"J. Mol. Biol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.bbalip.2018.08.009","article-title":"Small-molecule inhibitors as potential therapeutics and as tools to understand the role of phospholipases A2","volume":"1864","author":"Nikolaou","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0005-2760(84)90302-3","article-title":"Non-specific inhibition of enzymes by p-bromophenacyl bromide. Inhibition of human phospholipase C and modification of sulfhydryl groups","volume":"794","author":"Kyger","year":"1984","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s11745-016-4186-1","article-title":"Inhibition of Human Group IIA-Secreted Phospholipase A2 and THP-1 Monocyte Recruitment by Maslinic Acid","volume":"51","author":"Yap","year":"2016","journal-title":"Lipids"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s12038-018-9745-6","article-title":"Maslinic acid modulates secreted phospholipase A2-IIA (sPLA2-IIA)-mediated inflammatory effects in macrophage foam cells formation","volume":"43","author":"Yap","year":"2018","journal-title":"J. Biosci."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3923\/ijp.2018.187.193","article-title":"Inhibitory Effect of Sulforaphane on Secretory Group IIA Phospholipase A2","volume":"14","author":"Lee","year":"2018","journal-title":"Int. J. Pharmacol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s10753-015-0139-8","article-title":"Inhibitory Effect of Orientin on Secretory Group IIA Phospholipase A2","volume":"38","author":"Bae","year":"2015","journal-title":"Inflammation"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/19768354.2015.1087428","article-title":"Inhibitory effect of vicenin-2 and scolymoside on secretory group IIA phospholipase A2","volume":"19","author":"Lee","year":"2015","journal-title":"Anim. Cells Syst."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1475-2875-10-82","article-title":"Parasitostatic effect of maslinic acid. I. Growth arrest of Plasmodium falciparum intraerythrocytic stages","volume":"10","author":"Moneriz","year":"2011","journal-title":"Malar. J."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"23992","DOI":"10.1074\/jbc.271.39.23992","article-title":"Native peptide inhibition. Specific inhibition of type II phospholipases A2 by synthetic peptides derived from the primary sequence","volume":"271","author":"Tseng","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"33156","DOI":"10.1074\/jbc.M101272200","article-title":"A novel approach to the design of inhibitors of human secreted phospholipase A2 based on native peptide inhibition","volume":"276","author":"Church","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.bmcl.2012.10.080","article-title":"Identification of inhibitors against interaction between pro-inflammatory sPLA2-IIA protein and integrin alphavbeta3","volume":"23","author":"Ye","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"10815","DOI":"10.1038\/s41598-017-11219-8","article-title":"Structural basis for functional selectivity and ligand recognition revealed by crystal structures of human secreted phospholipase A2 group IIE","volume":"7","author":"Hou","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nchembio.118","article-title":"Network pharmacology: The next paradigm in drug discovery","volume":"4","author":"Hopkins","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"100325","DOI":"10.1016\/j.patter.2021.100325","article-title":"Integrative resource for network-based investigation of COVID-19 combinatorial drug repositioning and mechanism of action","volume":"2","author":"Azad","year":"2021","journal-title":"Patterns"},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Denti, V., Mahajneh, A., Capitoli, G., Clerici, F., Piga, L., Pagani, L., Chinello, C., Bolognesi, M.M., Paglia, G., and Galimberti, S. (2021). Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging. Metabolites, 11.","DOI":"10.3390\/metabo11090599"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41580-018-0094-y","article-title":"Spatial proteomics: A powerful discovery tool for cell biology","volume":"20","author":"Lundberg","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.cels.2021.03.002","article-title":"From cell biology to physiology using in situ single cell technologies","volume":"12","author":"Nagle","year":"2021","journal-title":"Cell Syst."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/23\/7267\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:37:54Z","timestamp":1760168274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/23\/7267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,30]]},"references-count":158,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["molecules26237267"],"URL":"https:\/\/doi.org\/10.3390\/molecules26237267","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,30]]}}}